Pre-market Hot Trades in US Stocks
OneConstruction, up 11.83% in pre-market trading, has no significant news recently. The trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
Ciena is up 3.14% in pre-market trading. Based on recent news,
<ol>
<li>
On March 15, analyst Saket Kalia stated that Ciena's first-quarter metrics were weaker than expected, and there is uncertainty regarding the leadership transition, leading to increased market caution. Barclays lowered its target price from $335 to $275.
</li>
<li>
On March 13, Ciena received a &#34;Buy&#34; rating from TD Cowen analysts, expecting it to benefit from AI infrastructure demand, pushing its stock price up by 1.1%.
</li>
<li>
On March 15, IREN Limited's stock price rose 14.74% this week, indicating strong market demand for its solid oxide fuel cells. Increased demand for AI infrastructure has led to positive market sentiment.
</li>
</ol>
Top Gainers in Pre-market US Stocks
Urgently is up 162.07% in pre-market trading. Based on recent key news:
<ol>
<li>
On March 14, Urgently announced a merger with Agero, with the merger price at a premium of about 171% over Thursday's closing price. This news drove Urgently's stock price up 161% in pre-market. Source: Zhitong Finance
</li>
<li>
On March 14, the merger between Urgently and Agero will combine both parties' cutting-edge technologies and extensive influence, enhancing services for automakers, insurance companies, and mobile service providers. This strategic move will revolutionize the industry, providing new growth and innovation opportunities for all stakeholders. Source: Zhitong Finance. Industry consolidation is accelerating, with technological innovation driving growth.
</li>
</ol>
CytomX Therapeutics is up 55.54% in pre-market trading. Based on recent key news:
<ol>
<li>
On March 16, CytomX Therapeutics announced its financial performance for 2025, showing strong cash reserves to support the advancement of its R&amp;D pipeline. Although revenue declined due to the completion of collaboration milestones, the company continues to prioritize late-stage projects. This news boosted market confidence, driving the stock price up. Source: Reuters
</li>
<li>
On March 16, CytomX Therapeutics announced positive clinical trial data for its Varsetatug Masetecan in late-stage colorectal cancer, showing potential as a new treatment option. This news further enhanced investors' optimistic expectations for the company's future development. Source: Reuters
</li>
<li>
On March 16, several analysts maintained a &#34;Buy&#34; rating on CytomX and raised the target price to $10, reflecting the market's optimism about the company's prospects. Source: Reuters. The biotechnology sector has been active recently, with significant capital inflows
Tianci pre-market rose 33.23%. Based on recent news,
</li>
<li>
On March 12, Tianci International Inc. released its financial report, showing that the company's total revenue increased by 52% year-on-year, reaching $7.7 million, mainly driven by new mineral trading activities and logistics expansion. This news boosted market confidence and drove the stock price up.
</li>
<li>
On March 12, the company completed a $7 million public offering and NASDAQ listing, supporting the expansion of the company's operations. This move further enhanced investors' confidence in the company's future development.
</li>
<li>
On March 13, Tianci International Inc. announced its net loss data, but due to revenue growth and operational expansion, the market remains optimistic about the company's prospects. Despite the losses, investors are full of expectations for the company's future profitability. Mineral trading and logistics expansion drove revenue growth
</li>
</ol>

ONEG

CIEN

OneConstruction pre-market up 11.83%; Ciena pre-market up 3.14%; Urgently pre-market up 162.07%; CytomX Therapeutics pre-market up 55.54%; Tianci pre-market up 33.23%

Pre-market hot trades in US stocks: OneConstruction up 11.83% pre-market; Ciena up 3.14% pre-market